We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.04B
AUM Growth
+$78.5M
Cap. Flow
-$21.3M
Cap. Flow %
-1.05%
Top 10 Hldgs %
16.88%
Holding
318
New
26
Increased
78
Reduced
63
Closed
17

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$18.2M
2
NVRO
NEVRO CORP.
NVRO
+$7.45M
3
EXAS
Exact Sciences
EXAS
+$6.7M
4
ZEN
ZENDESK INC
ZEN
+$5.02M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.99M

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$12.7M
2
AKAM icon
Akamai
AKAM
+$6.27M
3
SYF icon
Synchrony
SYF
+$5.49M
4
HRL icon
Hormel Foods
HRL
+$5.4M
5
ESRX
Express Scripts Holding Company
ESRX
+$4.27M

Sector Composition

Rank Sector Weight
1 Industrials 19.97%
2 Healthcare 18.77%
3 Technology 17.98%
4 Consumer Discretionary 12.95%
5 Financials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYL icon
26
Tyler Technologies
TYL
$13.7B
$18.7M 0.92%
106,358
+500
+0.5% +$83.1K
V icon
27
Visa
V
$677B
$18.3M 0.9%
195,604
+604
+0.3% +$56.1K
AMZN icon
28
Amazon
AMZN
$2.44T
$18.3M 0.9%
378,000
-2,000
-0.5% -$95.4K
MIDD icon
29
Middleby
MIDD
$6.01B
$17.2M 0.85%
141,900
– –
MA icon
30
Mastercard
MA
$498B
$17.2M 0.84%
141,500
– –
DPZ icon
31
Domino's
DPZ
$11.9B
$16.6M 0.82%
78,700
– –
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$123B
$16.6M 0.81%
129,000
-8,000
-6% -$963K
CNI icon
33
Canadian National Railway
CNI
$78.5B
$16.5M 0.81%
203,303
+703
+0.3% +$53.6K
DHR icon
34
Danaher
DHR
$138B
$16.2M 0.79%
216,576
– –
JAZZ icon
35
Jazz Pharmaceuticals
JAZZ
$16.1B
$15.6M 0.76%
100,000
-9,000
-8% -$1.38M
AMT icon
36
American Tower
AMT
$83.5B
$15.1M 0.74%
113,900
-2,000
-2% -$256K
LII icon
37
Lennox International
LII
$15B
$14.8M 0.73%
80,800
– –
ACN icon
38
Accenture
ACN
$106B
$14.4M 0.71%
116,800
– –
CASY icon
39
Casey's General Stores
CASY
$32.1B
$14.4M 0.7%
134,000
-800
-0.6% -$89.3K
ATR icon
40
AptarGroup
ATR
$8.69B
$14.2M 0.7%
163,900
– –
AYI icon
41
Acuity Brands
AYI
$9.99B
$14.2M 0.7%
70,000
– –
EW icon
42
Edwards Lifesciences
EW
$49.4B
$14.2M 0.7%
360,000
-51,000
-12% -$1.86M
ORLY icon
43
O'Reilly Automotive
ORLY
$75.1B
$14M 0.69%
960,000
– –
RAI
44
DELISTED
Reynolds American Inc
RAI
$13.7M 0.67%
211,000
– –
GD icon
45
General Dynamics
GD
$103B
$13.5M 0.66%
68,100
– –
BALL icon
46
Ball Corp
BALL
$17.5B
$13M 0.64%
308,400
– –
AZO icon
47
AutoZone
AZO
$51.3B
$13M 0.64%
22,800
– –
BABA icon
48
Alibaba
BABA
$276B
$13M 0.64%
92,000
– –
JJSF icon
49
J&J Snack Foods
JJSF
$1.49B
$12.9M 0.63%
97,600
+1,800
+2% +$240K
BAC icon
50
Bank of America
BAC
$429B
$12.9M 0.63%
530,000
+10,000
+2% +$233K
1
2
3 4 5

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, EULAV Asset Management held 318 positions worth $2.04B, up 4% from $1.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EULAV Asset Management's Q2 2017 filing shows 26 new, 78 increased, 63 reduced and 17 closed positions. Its largest new stake was Exact Sciences: 217,000 shares worth $7.67M. The largest sale was Valspar, an estimated $12.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • EULAV Asset Management's largest Q2 2017 buy was Exact Sciences: 217,000 shares worth $7.67M.
  • EULAV Asset Management added most to Alexion Pharmaceuticals in Q2 2017, an estimated $18.2M increase.
  • EULAV Asset Management's biggest Q2 2017 reduction was Hormel Foods, cutting an estimated $5.4M.
  • EULAV Asset Management fully exited Valspar in Q2 2017, selling an estimated $12.7M.
  • EULAV Asset Management's ten largest holdings make up 17% of its $2.04B portfolio in Q2 2017.
  • EULAV Asset Management opened 26 new positions and closed 17 in Q2 2017.
  • EULAV Asset Management's portfolio value rose 4% quarter-over-quarter to $2.04B.

Based on EULAV Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.